pyrazinamide has been researched along with Pneumococcal Infections in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Pneumococcal Infections: Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Peak plasma concentration (Cmax), Tmax, elimination half-life (t1/2e) and AUC0- infinity of alginate drugs were significantly higher than those of free drugs." | 1.32 | Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects. ( Garg, SK; Khuller, GK; Sharma, S, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, S | 1 |
| Khuller, GK | 1 |
| Garg, SK | 1 |
1 other study available for pyrazinamide and Pneumococcal Infections
| Article | Year |
|---|---|
Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects.
Topics: Administration, Oral; Alginates; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Area U | 2003 |